Updated study results of pelcitoclax (APG 1252) combined with osimertinib in patients (pts) with EGFR mutant non small cell lung cancer (NSCLC)
| Title | Updated study results of pelcitoclax (APG 1252) combined with osimertinib in patients (pts) with EGFR mutant non small cell lung cancer (NSCLC) |
|---|---|
| Description | Updated study results of pelcitoclax (APG 1252) combined with osimertinib in patients (pts) with EGFR mutant non small cell lung cancer (NSCLC) |
| Organism | Homo sapiens |
| Data Type | Other Type of Genomic Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA020089 |
| Release Date | 2023-10-25 |
| Submitter | Yifan Zhai (yzhai@ascentage.com) |
| Organization | Ascentage Pharma (Suzhou) Co., Ltd |
| Submission Date | 2023-09-25 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX004995-01 | APG1252NC101 (2023ESMO Submission PPT) | 1 | Other Type of Genomic Data | 2.3 MB | zip | 0 | Controlled |